Semi-Annual Statement Of Income

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7298504

Concept 2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
Semi-annual statement of income
Statement of income
Net sales
51,372,000,000 JPY
1,222,000,000 JPY
51,372,000,000 JPY
JPY
50,150,000,000 JPY
34,958,000,000 JPY
36,171,000,000 JPY
36,171,000,000 JPY
JPY
1,212,000,000 JPY
Cost of sales
17,269,000,000 JPY
16,450,000,000 JPY
Ordinary profit (loss)
19,823,000,000 JPY
5,722,000,000 JPY
Gross profit (loss)
34,103,000,000 JPY
19,720,000,000 JPY
Extraordinary income
0 JPY
5,000,000 JPY
Selling, general and administrative expenses
14,523,000,000 JPY
14,207,000,000 JPY
Extraordinary losses
588,000,000 JPY
69,000,000 JPY
Selling, general and administrative expenses
Salaries
2,804,000,000 JPY
2,821,000,000 JPY
Profit (loss) before income taxes
19,235,000,000 JPY
5,658,000,000 JPY
Operating profit (loss)
19,579,000,000 JPY
676,000,000 JPY
19,579,000,000 JPY
JPY
18,903,000,000 JPY
4,851,000,000 JPY
5,512,000,000 JPY
5,512,000,000 JPY
JPY
661,000,000 JPY
Non-operating income
341,000,000 JPY
277,000,000 JPY
Non-operating income
Interest income
15,000,000 JPY
4,000,000 JPY
Dividend income
288,000,000 JPY
251,000,000 JPY
Income taxes
4,949,000,000 JPY
1,590,000,000 JPY
Non-operating expenses
97,000,000 JPY
67,000,000 JPY
Non-operating expenses
Interest expenses
12,000,000 JPY
8,000,000 JPY
Profit (loss)
14,286,000,000 JPY
4,068,000,000 JPY
Extraordinary income
Extraordinary losses

Talk to a Data Expert

Have a question? We'll get back to you promptly.